ME/CFS Severely Ill, Big Data Study
The ME/CFS Severely Ill, Big Data Study, led by Ronald Davis, will conduct a comprehensive, “Big Data” analysis on severely ill ME/CFS patients with the goal of finding sensitive and distinctive molecular biomarker(s).
Phase One - comprehensive testing[edit | edit source]
The first phase of the trial includes a very wide array of biological tests which have been defined and published.[1]
...comprehensive/extensive testing of severely ill patients. By thoroughly checking blood, urine, and other body products, we expect to find biological abnormalities that could explain the debilitating symptoms. We don’t want to miss anything. So we’re doing it completely the first time.
In July 2016 it was announced that sample collection was complete.[2]
Preliminary results[edit | edit source]
In March 2016, it was announced that the study had a significant result in the area of mitochondria. This resulted in the addition of Robert Naviaux (a mitochondrial expert) to the research team.[3]
Results: Chemical signatures in blood[edit | edit source]
Metabolic features of chronic fatigue syndrome
